Thermo Presents Bath Circulators at the 2005 Biotechnica Show
News Oct 14, 2005
Thermo Electron Corporation has announced that it will present its HAAKE and NESLAB circulators in hall 2/booth B25 at Biotechnica, held October 18 - 20, 2005 in Hannover, Germany.
At the show, Thermo will introduce the HAAKE Phoenix II Series of bath circulators to the biotechnology industry.
“HAAKE Phoenix II circulators are noteworthy because of their large graphic displays that incorporate plain text dialogs and simple user interfaces for intuitive navigation,” said Silke Ebbing, product manager for Temperature Control product lines.
“Quick and easy temperature control laboratory applications are not only possible, but virtually guaranteed.”
The refrigerated HAAKE Phoenix II circulator on display handles temperature range from -28 to 150 °C with a temperature accuracy of +/- 0,01 K.
The integrated programmer can be operated in six languages, and the unit can be controlled via RS232 and RS485 interface.
Thermo also will display HAAKE C/DC circulators, inexpensive units that offer high power capacities, plus NESLAB RTE and EX Series bath circulators.
These workhorse units are designed for maximum performance in the lab with minimum space requirements.
For example, NESLAB RTE 740 refrigerated units have a heating capacity of 2 kW and a cooling capacity of 800 watts with a footprint of just 29 x 48 cm.
The tried-and-tested digital control and the pressure and suction pump ensure a high level of accuracy and reproducibility for temperature control within a range of -40 to 200 °C.
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018